Cue Biopharma Announces Appointment of Matteo Levisetti, M.D. as Senior Vice President of Clinical Development

NEXT STORY
SCYNEXIS Announces Licensing Agreement and Strategic Partnership with Hansoh Pharma for Rights to Ibrexafungerp in Greater China
PREV STORY
Global Blood Culture Tests Market (2020 to 2025) – Identification of Antibiotic-Resistant Microorganisms Presents Opportunities
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Cue Biopharma Announces Appointment of Matteo Levisetti, M.D. as Senior Vice President of Clinical Development

NEXT STORY
SCYNEXIS Announces Licensing Agreement and Strategic Partnership with Hansoh Pharma for Rights to Ibrexafungerp in Greater China
PREV STORY
Global Blood Culture Tests Market (2020 to 2025) – Identification of Antibiotic-Resistant Microorganisms Presents Opportunities
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

GBT Reports Second Quarter 2021 Financial Results

author_avatar
NASDAQ Market News

Curetis To Attend Key Investor and Scientific Conferences In The Third Quarter 2018

Curetis To Attend Key Investor and Scientific Conferences In The Third Quarter 2018 Amsterdam, ...

author_avatar
NASDAQ Market News

Immutep Completes a A$60 Million Placement to Expand its Clinical Development and Manufacturing Program into Late-Stage Settings

author_avatar
NASDAQ Market News